Virginia Retirement Systems Et Al Aerie Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 May 16, 2023	SELL	$6.37 - $15.23 $73,255 - $175,145	-11,500 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$5.64 - $9.8 $64,859 - $112,700	11,500 New	11,500 $105,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.